✦ LIBER ✦

Carboplatin therapy in advanced endometrial cancer

✍ Scribed by JB Green III; S Green; DS Alberts; R O'Toole; EA Surwit; JW Noltimier

Book ID: 118890517
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 273 KB
Volume: 34
Category: Article
ISSN: 0020-7292
DOI: 10.1016/0020-7292(91)90588-v

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carboplatin and paclitaxel in advanced o

Carboplatin and paclitaxel in advanced or metastatic endometrial cancer

✍ D. Pectasides; N. Xiros; G. Papaxoinis; E. Pectasides; C. Sykiotis; A. Koumarian 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Carboplatin and paclitaxel for the treat

Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer

✍ Tahira Akram; Priya Maseelall; James Fanning 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Gemcitabine/Carboplatin in Advanced Urot

Gemcitabine/Carboplatin in Advanced Urothelial Cancer

✍ Joan Carles; Miguel Nogué 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 777 KB

The Role of Radiation Therapy in Locally

The Role of Radiation Therapy in Locally Advanced Endometrial Cancer

✍ Penny R. Anderson 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Esorubicin in advanced endometrial cance

Esorubicin in advanced endometrial cancer: an ineffective and potentially toxic therapy

✍ Jacob B. Green; Stephanie Green; Robert V. O'Toole; David S. Alberts; William A. 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 181 KB

The Southwest Oncology Group conducted a phase II study of esorubicin treatment in patients with advanced endometrial cancer who had received no prior chemotherapy. Twenty of 31 patients were fully evaluable for response and toxicity. There were no clinical responses to treatment and 60% (12/20) of

Hormone therapy in advanced and recurren

Hormone therapy in advanced and recurrent endometrial cancer: a systematic review

✍ S.B. DECRUZE; J.A. GREEN 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB